Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.
about
Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Potential of gene therapy as a treatment for heart failureA novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and productionSwitching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.Enhancement of BMP-2 induced bone regeneration by SDF-1α mediated stem cell recruitment.The evolution of adenoviral vectors through genetic and chemical surface modifications.GLP-1-mediated gene therapy approaches for diabetes treatment.Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.Gene delivery in tissue engineering and regenerative medicine.Helper-Dependent Adenoviral Vectors and Their Use for Neuroscience Applications.Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts.Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver.Stem cell attraction via SDF-1α expressing fat tissue grafts.High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors.Advancements in the design and scalable production of viral gene transfer vectors.Sustained secretion of anti-tumor necrosis factor α monoclonal antibody from ex vivo genetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis.
P2860
Q34485522-26E6B28D-39EB-4BCF-AE67-78A6585859E3Q35641704-FCAC3ECC-3698-4378-8B6A-52ECF0A8130FQ36497159-7253AA91-5B5B-445B-81FD-BADBA15F67D7Q37153341-D313AC85-0471-4CD9-A5FB-AA54B4144D42Q37547783-F0C76674-F6CF-4984-83DB-6CD9F0660915Q37587945-FDF006F9-AF65-4400-9C2F-B487EB8DD022Q38189250-E6385D9A-3635-4628-999B-6835D1C1845DQ38199215-D410C7DA-A085-45FF-8F4F-EFE9F942F2C9Q38295771-742663F5-9B2C-438C-B73D-A2EE1BBC8856Q38306886-B17F4686-624F-4FB5-BED0-DD7A09D8CD81Q38436558-9C387A11-2D33-4C40-B5DD-4EB253D6E4EFQ38743580-08172984-00D5-4032-9B14-4BCF4B7B3A1EQ38763953-80B217C7-51B1-478E-90FE-26D9EBBA8CC6Q39183606-F8032A9A-55EC-4F99-A7DC-29794F5FFF9DQ40675932-0E448FF0-B3BD-4514-9320-19ECAD6AFBEFQ41124092-3D3826AB-1C08-451E-8015-54ECF6EEBFADQ41931475-12E2A423-3C51-4C2E-9AB1-A492A40E281CQ45869248-809CDC53-22ED-4AD5-B00F-7C59BFCD4B56
P2860
Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gene therapy with helper-depen ...... ances and future perspectives.
@en
Gene therapy with helper-depen ...... ances and future perspectives.
@nl
type
label
Gene therapy with helper-depen ...... ances and future perspectives.
@en
Gene therapy with helper-depen ...... ances and future perspectives.
@nl
prefLabel
Gene therapy with helper-depen ...... ances and future perspectives.
@en
Gene therapy with helper-depen ...... ances and future perspectives.
@nl
P2860
P356
P1433
P1476
Gene therapy with helper-depen ...... ances and future perspectives.
@en
P2093
Francesco Vetrini
P2860
P304
P356
10.3390/V2091886
P577
2010-09-03T00:00:00Z